-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$50.6746.61% Upside
Harmony Biosciences Holdings, Inc. Frequently Asked Questions
-
What analysts cover Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. has been rated by research analysts at UBS, Mizuho Securities, Oppenheimer, Needham, Raymond James, Jefferies in the past 90 days.